Peak severity: Weeks 4 to 12, often worsening with each dose increase
Your Ro-affiliated provider may recommend the use of Ozempic as treatment for chronic weight management (obesity or overweight)
Clinical trials have shown significant weight reduction in many patients using the medication
This is time-limited and not yet permanent policy, but it's a meaningful development for the 65+ population managing obesity alongside diabetes or heart disease
Sustainable weight loss strategies still exist, simpler food choices, steady exercise, better sleep, and honest medical review
Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or References Fleming TP, Watkins AJ, Velazquez MA, Mathers JC, Prentice AM, Stephenson J, et al